CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, has joined the Accelerating Medicines Partnership® (AMP®) Heart Failure ...
Simultaneous publication in Journal of the American College of Cardiology demonstrates impact of ECG-AI on heart failure risk assessment Anumana, a leader in AI-powered cardiovascular diagnostics, ...
The MarketWatch News Department was not involved in the creation of this content. Simultaneous publication in Journal of the American College of Cardiology demonstrates impact of ECG-AI on heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback